MultipleMS

Proudly presenting the genetic and genomic map of multiple sclerosis! Press release: bit.ly/2n3oBJu Paper in Science: bit.ly/2lv5bgk Personal notes: bit.ly/2nIAxRl #multiplesclerosis @BrighamResearch @broadinstitute @harvardmed @mssociety @AnnRomney

Face-to-face meeting Stockholm The yearly general assemble meeting is ongoing in Stockholm. A large part of the active collaborating parties in MultipleMS is presenting their status updates and future plans. Most of us will continue this week with the yearly ECTRIMS conference.

The Laboratory for Neuroimmunology @KU_Leuven featured in the latest @MultipleMS_EU newsletter #H2020 #Horizon2020 #iWiMS #MultipleSclerosis #Research

Our latest newsletter is here :) To register for our e-mail list, please go to: multiplems.eu/newsletters/

We thank everybody who attended our very successfull workshop for stakeholders and consortium members of the EU-Horizon 2020-funded project "MultipleMS" in London May 16th 2018. We are looking forward to bring this great project forward in collaboration with you all.

We are happy to announce the inclusion of the first Norwegian patient in the prospective MultipleMS cohort (January 8th 2018)

Are you interested in MS research? Please help us identify the most urgent needs in MS by filling out this survey: multiplems.eu/events/mms-sur…

MultipleMS executive board members explains why the project is important to them: facebook.com/MultipleMS/pho…

Newly published data from one of our members, congratulations! twitter.com/ccots/status/8…

The main objective of MultipleMS is to develop novel personalised medicine approaches for MS patients multiplems.eu/objectives/

Global partnership launched to enable personalized therapies in multiple sclerosis - multiplems.eu

Inspiring words from Maja Jagodic, Senior researcher at Karolinska Institutet and member of MultipleMS facebook.com/MultipleMS/pho… … …

MultipleMS, now on Twitter. Please follow us at Facebook (MultipleMS EU Horizon2020) and at hour official webpage (multiplems.eu)